Article Link: FDA Approves Accelerated 7-Day Vaccine Dosing Schedule for Ixiaro

GAITHERSBURG, Md.–(BUSINESS WIRE) October 05, 2018 –Valneva USA, the U.S. subsidiary of global vaccine biotech company Valneva SE, today announced U.S. Food and Drug Administration (FDA) approval of an accelerated dosing regimen for Ixiaro…

Source: FDA New Drug Approvals